JohnsonMDCampbellLKCampbellRK. Troglitazone: Review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus. Ann Pharmacother1998;32:337–48.
2.
Product label. Rezulin (troglitazone) tablets. Morris-Plains, NJ: Parke-Davis, January 1997.
3.
LoiCMSternRVassosABKoupJRSedmanA. Effect of troglitazone on terfenadine pharmacokinetics (abstract). Clin Pharmacol Ther1998;63:228.
4.
LoiCMKnowltonPSternRKoupJRVassosABSedmanAJ. Effect of troglitazone on terfenadine pharmacokinetics when dosed 4-hours apart (abstract). Clin Pharmacol Ther1998;63:228.
5.
MichaletsEL. Update: Clinically significant cytochrome P-450 drug interactions. Pharmacotherapy1998;18:84–112.
6.
AndersonGLoiCM. Effect of troglitazone on urinary excretion of cortisol and 6-β-hydroxycortisol (abstract). Clin Pharmacol Ther1998;63:228.
7.
FleishakerJCPearsonLKPetersGR. Phenytoin causes a rapid increase in 6-beta-hydroxycortisol urinary excretion in humans — A putative measure of CYP3A induction. J Pharm Sci1995;84:292–4.
8.
GedCRouillonJMPichardLCombalbertJBressotNBoriesPThe increase in urinary excretion of 6-beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol1989;28:373–87.
